Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis”

This publication has 25 references indexed in Scilit:

• Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
  The Lancet Respiratory Medicine, 2018
• Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
  New England Journal of Medicine, 2018
• FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease
  American Journal of Respiratory and Critical Care Medicine, 2017
• Network meta-analysis: a technique to gather evidence from direct and indirect comparisons
  Pharmacy Practice, 2017
• Network meta-analysis: an introduction for clinicians
  Internal and Emergency Medicine, 2016
• The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study
  npj Primary Care Respiratory Medicine, 2016
• Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report
  Value in Health, 2014
• Consistency and inconsistency in network meta‐analysis: concepts and models for multi‐arm studies
  Research Synthesis Methods, 2012
• Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2
  Value in Health, 2011
• Random-Effects Meta-Analyses Are Not Always Conservative
  American Journal of Epidemiology, 1999